Zobrazeno 1 - 10
of 39
pro vyhledávání: '"M J Mackie"'
Autor:
B. A. McVerry, P. Moreton, J. A. Child, M. R. Howard, G. M. Smith, S. Bolam, Gareth J. Morgan, D. Gilson, J. M. Davies, M. J. Mackie, S. S. Jalihal, L. A. Parapia, A. T. Williams
Publikováno v:
Cancer Chemotherapy and Pharmacology. 53:324-328
We have developed and evaluated a CNS-targeted chemotherapy regimen based on the pharmacokinetic properties of the individual drugs in the combination.In a twin-track study, 16 patients with secondary CNS lymphoma (SCNSL) and 8 with primary CNS lymph
Publikováno v:
Hematology. 8:211-220
All cases S16 years of age with a histological diagnosis of non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) presented in Scotland between 1 January 1994 and 31 December 1996 were registered prospectively in the Scotland and Newcastle Lymphoma
Autor:
P S Ganly, P Chu, M P Wilson, A Smith, S. M. Tollerfield, Atul Mehta, M Deane, M J Mackie, S. A. Johnson, Timothy Littlewood, Peter Carey, J Brookes, A Duncombe, Stephen Schey, Graham Jackson, Michael Hutchinson, G E Turner, G. M. Smith, P. R. A. Taylor, Robert Marcus
Publikováno v:
British Journal of Haematology. 112:127-137
The primary objective of this study was to determine the complete remission (CR) rate achieved with the FLAG (fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor) regimen in patients with relapsed or refractory acute myeloid l
Publikováno v:
Clinical & Laboratory Haematology. 22:97-102
Fluorescence in situ hybridization (FISH) is increasingly used as an adjunct to conventional cytogenetic analysis in the diagnosis of haematological malignancies and in monitoring minimal residual disease. FISH, however, is generally performed on sli
Autor:
Brian Angus, M. K. Cook, A. Heppleston, Adrian L. Harris, R. C. F. Leonard, J. T. Roberts, Angela Dawson, Robin J Prescott, Anne Lennard, R. G. B. Evans, S. J. Proctor, H Lucraft, P Dawes, J. B. Macgillivray, A. M. Lessells, A. S. Krajewski, W. D. Thompson, M. J. Galloway, A. C. Parker, David Cameron, J. M. White, C. H. W. Horne, Paul Taylor, M. J. Mackie
Publikováno v:
European Journal of Cancer. 33:1195-1201
The aim of this study was to test whether survival for patients with high-grade non-Hodgkin's lymphoma (NHL) can be improved with a non-cross-resistant regimen as compared to a CHOP-based regimen. This is a multicentre study comprising 325 adult pati
Publikováno v:
Gut. 38:120-124
Iron deficiency anaemia may be due to occult bleeding into the gut. However, although clinical investigations may show a high frequency of gastrointestinal tract disease in these patients, the cause-effect relationship between the lesions detected an
Autor:
A Dawson, S. J. Proctor, Graham Jackson, P. R. A. Taylor, Anne Lennard, H. L. Lucraft, Brian Angus, A Hepplestone, M. J. Mackie, Robin J Prescott, J. M. White
Publikováno v:
European journal of cancer (Oxford, England : 1990). 38(6)
The aim of the study was to identify all patients with poor risk Hodgkin’s disease (HD) using a numerical prognostic index in a defined population and to recruit them into a trial of intensive chemotherapy prednisolone, vinblastine, doxorubicin, ch
Publikováno v:
Clinical and laboratory haematology. 22(2)
Fluorescence in situ hybridization (FISH) is increasingly used as an adjunct to conventional cytogenetic analysis in the diagnosis of haematological malignancies and in monitoring minimal residual disease. FISH, however, is generally performed on sli
Publikováno v:
Clinical & Laboratory Haematology. 5:427-428
Autor:
D A, Cameron, J M, White, S J, Proctor, R J, Prescott, R C, Leonard, B, Angus, M K, Cook, P J, Dawes, A A, Dawson, R G, Evans, M J, Galloway, A L, Harris, A, Heppleston, C H, Horne, A S, Krajewski, A L, Lennard, A M, Lessells, H H, Lucraft, J B, MacGillivray, M J, Mackie, A C, Parker, J T, Roberts, P R, Taylor, W D, Thompson
Publikováno v:
European journal of cancer (Oxford, England : 1990). 33(8)
The aim of this study was to test whether survival for patients with high-grade non-Hodgkin's lymphoma (NHL) can be improved with a non-cross-resistant regimen as compared to a CHOP-based regimen. This is a multicentre study comprising 325 adult pati